Ailed Cruz‐Collazo

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice”.

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

Pharmaceutics(2020)10.3390/pharmaceutics12100975

N/A

0DataRank · unranked

11 citations

María del Mar Maldonado, Matilde Merino‐Sanjuán, Ailed Cruz‐Collazo, Jean F. Ruiz-Calderón, Víctor Mangas‐Sanjuán +3 more

Data from Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer

(2023)10.1158/1535-7163.c.6543291

N/A

0DataRank · unranked

0 citations

Jean F. Ruiz-Calderón, Hector Picon, Luis D. Borrero-García, Irmaris Lopez, Linette Castillo‐Pichardo +8 more

Data from Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer

(2023)10.1158/1535-7163.c.6543291.v1

N/A

0DataRank · unranked

0 citations

Jean F. Ruiz-Calderón, Hector Picon, Luis D. Borrero-García, Irmaris Lopez, Linette Castillo‐Pichardo +8 more

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

Translational Oncology(2024)10.1016/j.tranon.2024.101928

N/A

0DataRank · unranked

5 citations

Michael J. Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas‐Mejía, Miciely Aponte-Reyes, Ailed Cruz‐Collazo +6 more